On September 15, 2026, Pulse Biosciences, Inc. entered into an equity distribution agreement with Mizuho Securities USA LLC. This agreement allows the company to offer and sell shares of its common stock with an aggregate offering price of up to $85 million. The company has no obligation to sell any shares, providing flexibility in their financing strategy.
Company Information
Company
Pulse Biosciences, Inc.
Location
3957 POINT EDEN WAY
Hayward, California, United States
About
Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue.
Don't miss Pulse Biosciences, Inc.'s next move
Get an email the moment Pulse Biosciences, Inc. raises, hires an exec, or expands, usually minutes after it happens.
HaywardBiotechnologyHealth CareMedicalTherapeutics